Free Trial
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$143.00
+0.82 (+0.58%)
(As of 10/8/2024 ET)

About iShares Biotechnology ETF (NASDAQ:IBB)

Key Stats

Today's Range
$141.99
$143.38
50-Day Range
$138.19
$149.47
52-Week Range
$111.83
$150.57
Volume
608,470 shs
Average Volume
1.49 million shs
Market Capitalization
$7.46 billion
Assets Under Management
$7.32 billion
Dividend Yield
0.31%
Net Expense Ratio
0.45%
Aggregate Rating
Moderate Buy

ETF Overview

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.45%0.56%0.55%0.49%0.52%
Other Expenses0.00%0.33%0.49%0.41%0.54%
Total Expense0.45%0.71%0.70%0.63%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.33%-0.58%
Net Expense0.45%0.61%0.61%0.56%0.59%
Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

IBB ETF News Headlines

Digital interface with hologram of dna and hud with icons of lungs, pills, thermometer, syringe, emergency call, diagnostics, pie diagram. Concept of future technologies in health care. 3d rendering — Photo
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now (IBB)
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.
Biotech stocks
Biotech Breakout: Stocks for Your Watchlist
The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150.
[SHOCKING] Crypto Document Leak…
The crypto market waits for no one. And my team of experts and I believe that a BIG move is right around the corner. That's why we're offering you instant access to the game-changing book that's transforming average investors into massive crypto successes.
See More Headlines

IBB ETF - Frequently Asked Questions

iShares Biotechnology ETF's stock was trading at $135.85 at the start of the year. Since then, IBB shares have increased by 5.3% and is now trading at $143.00.
View the best growth stocks for 2024 here
.

Shares of iShares Biotechnology ETF split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Top institutional shareholders of iShares Biotechnology ETF include Appleton Partners Inc. MA (0.14%), Chesley Taft & Associates LLC (0.06%), Mirador Capital Partners LP (0.06%) and Perkins Coie Trust Co (0.05%).

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO) and Micron Technology (MU).

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
ICE Biotechnology Index (TR) (USD)
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
219

Fund Statistics

Assets Under Management
$7.32 billion
Average Daily Volume
$1.11 million
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
JPMorgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
3,080
Put Options
2,458
Call Options
622
Short Interest
9,300,000 shs

Miscellaneous

Beta
0.84
Creation Unit
50,000
Creation Fee
$614.00
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure


This page (NASDAQ:IBB) was last updated on 10/8/2024 by MarketBeat.com Staff
From Our Partners